Moshirfar Majid, Imbornoni Lauren M, Ostler Erik M, Muthappan Valliammai
Moran Eye Center, Department of Ophthalmology and Visual Sciences, University of Utah, Salt Lake City, UT, USA.
University of Arizona College of Medicine, Tucson, AZ, USA.
Clin Ophthalmol. 2014 Apr 8;8:711-6. doi: 10.2147/OPTH.S59878. eCollection 2014.
To evaluate the incidence rate and indications for explantation of Verisyse phakic intraocular lenses (pIOLs) over a 13.6 year period.
Case series describing six cases of explantation of Verisyse pIOLs, out of 213 eyes with Verisyse pIOLs, implanted over a 13.6 year period by one surgeon at one institution, with mean follow-up of 5.6 years per eye.
Four pIOLs were removed to facilitate extraction of a visually significant cataract, one was removed due to both cataract formation and development of corneal decompensation, and another was removed due to development of localized peripheral corneal decompensation. The incidence rate of pIOL removal was five per 1,000 patient-years with pIOL. Mean time from insertion of pIOL to cataract removal was 9.3 years (range 4.0-12.6 years). Mean time from insertion of pIOL to development of corneal decompensation was 10 years (range 6.9-13 years). There was no increase in the rate of cataract extraction in the pIOL population compared to the general population.
Cataracts may develop in patients with pIOLs, necessitating removal of the pIOL. Corneal decompensation is a serious complication that appears to be directly related to pIOLs. Corneal decompensation can occur up to 13 years following implantation of pIOLs, and long-term follow-up is important to monitor for this complication.
评估Verisyse有晶状体眼人工晶状体(pIOL)在13.6年期间的取出发生率及取出指征。
病例系列描述了在13.6年期间由一名外科医生在一家机构植入Verisyse pIOL的213眼中,有6例Verisyse pIOL取出的情况,每只眼平均随访5.6年。
4枚pIOL因便于取出具有明显视力影响的白内障而被取出,1枚因白内障形成和角膜失代偿发展而被取出,另一枚因局限性周边角膜失代偿发展而被取出。pIOL取出的发生率为每1000患者 - 年有5例。从pIOL植入到白内障取出的平均时间为9.3年(范围4.0 - 12.6年)。从pIOL植入到角膜失代偿发展的平均时间为10年(范围6.9 - 13年)。与普通人群相比,pIOL人群中的白内障摘除率没有增加。
pIOL患者可能会发生白内障,需要取出pIOL。角膜失代偿是一种严重并发症,似乎与pIOL直接相关。角膜失代偿可在pIOL植入后长达13年发生,长期随访对于监测这种并发症很重要。